MEDICURE INC. Files August 2024 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Aug 26, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Aug 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: MCU
TL;DR
MEDICURE INC. (MCU) filed its August 6-K, confirming foreign private issuer status and 20-F filing.
AI Summary
On August 26, 2024, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of August 2024 and indicates that the company is a foreign private issuer filing under Form 20-F. The filing provides information regarding the company's operations and financial reporting.
Why It Matters
This filing provides an update on MEDICURE INC.'s regulatory disclosures as a foreign private issuer, which is important for investors tracking the company's compliance and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- MEDICURE INC. (company) — Registrant
- 20240826 (date) — Filing Date
- August 2024 (date) — Reporting Period
- 001-31995 (other) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing for MEDICURE INC.?
The primary purpose is to report information as a foreign private issuer for the month of August 2024, indicating it files annual reports under Form 20-F.
What is MEDICURE INC.'s SEC file number?
MEDICURE INC.'s SEC file number is 001-31995.
What is the company's principal executive office address?
The company's principal executive office is located at 2-1250 Waverley Street, Winnipeg, MB, Canada R3T 6C6.
Does MEDICURE INC. file its annual reports on Form 20-F or Form 40-F?
MEDICURE INC. files its annual reports under cover of Form 20-F.
Is MEDICURE INC. submitting this Form 6-K in paper format?
The filing indicates that the registrant is not submitting the Form 6-K in paper format as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Filing Stats: 248 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-08-26 16:56:55
Filing Documents
- med_6k.htm (6-K) — 12KB
- med_ex991.htm (EX-99.1) — 14KB
- med_ex992.htm (EX-99.2) — 22KB
- med_ex992img9.jpg (GRAPHIC) — 215KB
- med_ex992img33.jpg (GRAPHIC) — 24KB
- med_ex992img32.jpg (GRAPHIC) — 41KB
- med_ex992img31.jpg (GRAPHIC) — 153KB
- med_ex992img30.jpg (GRAPHIC) — 212KB
- med_ex992img3.jpg (GRAPHIC) — 192KB
- med_ex992img29.jpg (GRAPHIC) — 191KB
- med_ex992img28.jpg (GRAPHIC) — 235KB
- med_ex992img27.jpg (GRAPHIC) — 214KB
- med_ex992img34.jpg (GRAPHIC) — 187KB
- med_ex992img35.jpg (GRAPHIC) — 192KB
- med_ex992img36.jpg (GRAPHIC) — 164KB
- med_ex992img8.jpg (GRAPHIC) — 214KB
- med_ex992img7.jpg (GRAPHIC) — 264KB
- med_ex992img6.jpg (GRAPHIC) — 234KB
- med_ex992img5.jpg (GRAPHIC) — 166KB
- med_ex992img4.jpg (GRAPHIC) — 39KB
- med_ex992img39.jpg (GRAPHIC) — 38KB
- med_ex992img38.jpg (GRAPHIC) — 24KB
- med_ex992img37.jpg (GRAPHIC) — 24KB
- med_ex992img26.jpg (GRAPHIC) — 259KB
- med_ex992img25.jpg (GRAPHIC) — 252KB
- med_ex992img1.jpg (GRAPHIC) — 39KB
- med_ex992img10.jpg (GRAPHIC) — 240KB
- med_ex992img11.jpg (GRAPHIC) — 229KB
- med_ex992img12.jpg (GRAPHIC) — 246KB
- med_ex992img13.jpg (GRAPHIC) — 211KB
- med_ex992img14.jpg (GRAPHIC) — 248KB
- med_ex992img15.jpg (GRAPHIC) — 163KB
- med_ex992img16.jpg (GRAPHIC) — 183KB
- med_ex992img17.jpg (GRAPHIC) — 256KB
- med_ex992img18.jpg (GRAPHIC) — 224KB
- med_ex992img24.jpg (GRAPHIC) — 191KB
- med_ex992img23.jpg (GRAPHIC) — 240KB
- med_ex992img22.jpg (GRAPHIC) — 257KB
- med_ex992img21.jpg (GRAPHIC) — 245KB
- med_ex992img20.jpg (GRAPHIC) — 259KB
- med_ex992img2.jpg (GRAPHIC) — 198KB
- med_ex992img19.jpg (GRAPHIC) — 223KB
- 0001654954-24-011091.txt ( ) — 9948KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: August 26, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3